Estrogen-plus-progestin use and mammographic density in postmenopausal women: Women's health initiative randomized trial

Journal of the National Cancer Institute

Volumn 97, Issue 18, 2005, Pages 1366-1376

  McTiernan, Anne ^a,b,c   Martin, Christopher F ^d   Peck, Jennifer D ^e   Aragaki, Aaron K ^a   Chlebowski, Rowan T ^f   Pisano, Etta D ^d   Wang, C Y ^a   Brunner, Robert L ^g   Johnson, Karen C ^h,h   Manson, JoAnn E ⁱ   Lewis, Cora E ^j   Kotchen, Jane Morley ^k   Hulka, Barbara S ^d   Alving, Barbara ^l   Rossouw, Jacques ^l   Pottern, Linda ^l   Prentice, Ross ^a   Anderson, Garnet ^a   LaCroix, Andrea ^a   Patterson, Ruth E ^a   Shumaker, Sally ^m   Rautaharju, Pentti ^m   Stein, Evan ⁿ   Cummings, Steven ^o   Himes, John ^p   Psaty, Bruce ^q   Wassertheil Smoller, Sylvia ^r   Hays, Jennifer ^s   Assaf, Annlouise R ^t   Phillips, Lawrence ^u   Beresford, Shirley ^a   Hsia, Judith ^v   Ritenbaugh, Cheryl ^w   Caan, Bette ^x   Howard, Barbara V ^y   Van Horn, Linda ^z   Black, Henry ^aa   Stefanick, Marcia L ^ab   Lane, Dorothy ^ac   Jackson, Rebecca ^ad   Lewis, Cora Beth ^ae   Bassford, Tamsen ^af   Wactawski Wende, Jean ^ag   Robbins, John ^ah   Hubbell, Allan ^ai   Judd, Howard ^f   Langer, Robert D ^aj   Gass, Margery ^ak   Limacher, Marian ^al   Curb, David ^am   Wallace, Robert ^an   Ockene, Judith ^ao   Lasse, Norman ^ap   O'Sullivan, Mary Jo ^aq   Margolis, Karen ^p   Brunner, Robert ^g   Heiss, Gerardo ^d,l,ar   Kuller, Lewis ^as   Brzyski, Robert ^at   Sarto, Gloria ^au   Bonds, Denise ^m   more..

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c Seattle Children's Hospital   (United States)

^d IL   (United States)

^e UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g UNIVERSITY OF NEVADA   (United States)

^h UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

ⁱ BRIGHAM AND WOMEN S HOSPITAL   (United States)

^j University of Alabama at Birmingham   (United States)

^k MEDICAL COLLEGE OF WISCONSIN   (United States)

^l NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^m WAKE FOREST SCHOOL OF MEDICINE   (United States)

ⁿ Pharmaceutical Product Development   (United States)

^o UNIVERSITY OF CALIFORNIA   (United States)

^p UNIVERSITY OF MINNESOTA   (United States)

^q UNIVERSITY OF WASHINGTON   (United States)

^r ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^s BAYLOR COLLEGE OF MEDICINE   (United States)

^t BROWN UNIVERSITY   (United States)

^u EMORY UNIVERSITY   (United States)

^v GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

^w CENTER FOR HEALTH RESEARCH   (United States)

^x DIVISION OF RESEARCH   (United States)

^y HOWARD UNIVERSITY   (United States)

^z NORTHWESTERN UNIVERSITY   (United States)

^aa RUSH UNIVERSITY MEDICAL CENTER   (United States)

^ab STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^ac STONY BROOK UNIVERSITY   (United States)

^ad OHIO STATE UNIVERSITY   (United States)

^ae UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^af UNIVERSITY OF ARIZONA   (United States)

^ag UNIVERSITY AT BUFFALO   (United States)

^ah UNIVERSITY OF CALIFORNIA   (United States)

^ai UNIVERSITY OF CALIFORNIA   (United States)

^aj UNIVERSITY OF CALIFORNIA   (United States)

^ak UNIVERSITY OF CINCINNATI   (United States)

^al UNIVERSITY OF FLORIDA   (United States)

^am UNIVERSITY OF HAWAII   (United States)

^an UNIVERSITY OF IOWA   (United States)

^ao UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^ap UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

^aq UNIVERSITY OF MIAMI   (United States)

^ar UNIVERSITY OF NORTH CAROLINA   (United States)

^as UNIVERSITY OF PITTSBURGH   (United States)

^at UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^au UNIVERSITY OF WISCONSIN MADISON   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CONJUGATED ESTROGEN PLUS MEDROXYPROGESTERONE ACETATE; PLACEBO; CONJUGATED ESTROGEN; MEDROXYPROGESTERONE ACETATE;

ADULT; AGED; AGING; ARTICLE; BREAST CANCER; CANCER RISK; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DEMOGRAPHY; ETHNIC DIFFERENCE; FEMALE; FOLLOW UP; HORMONE SUBSTITUTION; HUMAN; IMAGE ANALYSIS; IMAGE DISPLAY; MAJOR CLINICAL STUDY; MAMMOGRAPHY; PATIENT COMPLIANCE; POSTMENOPAUSE; PRIORITY JOURNAL; RACE DIFFERENCE; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; STATISTICAL ANALYSIS; STATISTICAL MODEL; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME; AGE; BREAST; BREAST TUMOR; DRUG EFFECT; ESTROGEN THERAPY; METHODOLOGY; MIDDLE AGED; MULTICENTER STUDY; PATHOLOGY; RISK FACTOR; UNITED STATES; WOMEN'S HEALTH;

AGE FACTORS; AGED; BREAST; BREAST NEOPLASMS; ESTROGEN REPLACEMENT THERAPY; ESTROGENS, CONJUGATED (USP); FEMALE; HUMANS; MAMMOGRAPHY; MEDROXYPROGESTERONE 17-ACETATE; MIDDLE AGED; POSTMENOPAUSE; RESEARCH DESIGN; RISK FACTORS; UNITED STATES; WOMEN'S HEALTH;

EID: 25144491673     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/dji279     Document Type: Article

References (28)

1. Kerlikowske K, Grady D, Barclay J, Sickles EA, Ernster V. Effect of age, breast density, and family history on the sensitivity of first screening mammography. JAMA 1996;276:33-8.
2. Tabar L, Fagerberg G, Chen HH, Duffy SW, Smart CR, Gad A, et al. Efficacy of breast cancer screening by age. New results from the Swedish Two-County Trial. Cancer 1995;75:2507-17.
3. Carney PA, Miglioretti DL, Yankaskas BC, Kerlikowske K, Rosenberg R, Rutter CM, et al. Individual and combined effects of age, breast density, and hormone replacement therapy use on the accuracy of screening mammography. Ann Intern Med 2003;138:168-75.
4. Boyd NF, Lockwood GA, Byng JW, Tritchler DL, Yaffe MJ. Mammographic densities and breast cancer risk. Cancer Epidemiol Biomarkers Prev 1998;7:1133-44.
5. Byrne C, Schairer C, Brinton LA, Wolfe J, Parekh N, Salane M, et al. Effects of mammographic density and benign breast disease on breast cancer risk (United States). Cancer Causes Control 2001;12:103-10.
6. Ursin G, Ma H, Wu AH, Bernstein L, Salane M, Parisky YR, et al. Mammographic density and breast cancer in three ethnic groups. Cancer Epidemiol Biomarkers Prev 2003;12:332-8.
7. Byrne C, Schairer C, Wolfe J, Parekh N, Salane M, Brinton LA, et al. Mammographic features and breast cancer risk: Effects with time, age, and menopause status. J Natl Cancer Inst 1995;87:1622-9.
8. Ziv E, Tice J, Smith-Bindman R, Shepherd J, Cummings S, Kerlikowske K. Mammographic density and estrogen receptor status of breast cancer. Cancer Epidemiol Biomarkers Prev 2004;13:2090-5.
9. Boyd N, Martin L, Stone J, Little L, Minkin S, Yaffe M. A longitudinal study of the effects of menopause on mammographic features. Cancer Epidemiol Biomarkers Prev 2002;11(10 Pt 1):1048-53.
10. Rutter CM, Mandelson MT, Laya MB, Seger DJ, Taplin S. Changes in breast density associated with initiation, discontinuation, and continuing use of hormone replacement therapy. JAMA 2001;285:171-6.
11. Persson I, Thurfjell E, Holmberg L. Effect of estrogen and estrogen-progestin replacement regimens on mammographic breast parenchymal density. J Clin Oncol 1997;15:3201-7.
12. Freedman M, San Martin J, O'Gorman J, Eckert S, Lippman ME, Lo SC, et al. Digitized mammography: A clinical trial of postmenopausal women randomly assigned to receive raloxifene, estrogen, or placebo. J Natl Cancer Inst 2001;93:51-6.
13. Greendale GA, Reboussin BA, Slone S, Wasilauskas C, Pike MC, Ursin G. Postmenopausal hormone therapy and change in mammographic density. J Natl Cancer Inst 2003;95:30-7.
14. Chlebowski RT, Hendrix SL, Langer RD, Stefanick ML, Gass M, Lane D, et al. Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: The Women's Health Initiative Randomized Trial. JAMA 2003;289:3243-53.
15. Writing Group for the Women's Health Initiative. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the women's health initiative randomized controlled trial. JAMA 2002;288:321-33.
16. The Women's Health Initiative Study Group. Design of the Women's Health Initiative clinical trial and observational study. Control Clin Trials 1998;19:61-109.
17. Colacurci N, Fornaro F, De Franciscis P, Mele D, Palermo M, del Vecchio W. Effects of a short-term suspension of hormone replacement therapy on mammographic density. Fertil Steril 2001;76:451-5.
18. American College of Radiology (ACR). ACR BI-RADS (r)-Mammography. 4th edition. In: ACR breast imagine reporting and data system, breast imaging atlas. Reston (VA): American College of Radiology; 2003.
19. Boyd NF, Byng JW, Jong RA, Fishell EK, Little LE, Miller AB, et al. Quantitative classification of mammographic densities and breast cancer risk: Results from the Canadian National Breast Screening Study. J Natl Cancer Inst 1995;87:670-5.
20. American College of Radiology (ACR) Illustrated Breast Imaging Reporting and Data System (BI-RADS). 3rd ed. Reston (VA): American College of Radiology; 1998.
21. McTiernan A, Kooperberg C, White E, Wilcox S, Coates R, Adams-Campbell LL, et al. Recreational physical activity and the risk of breast cancer in postmenopausal women: The Women's Health Initiative Cohort Study. JAMA 2003;290:1331-6.
22. Cuzick J, Warwick J, Pinney E, Warren RM, Duffy SW. Tamoxifen and breast density in women at increased risk of breast cancer. J Natl Cancer Inst. 2004;96:621-8.
23. Rutter CM, Mandelson MT, Laya MB, Seger DJ, Taplin S. Changes in breast density associated with initiation, discontinuation, and continuing use of hormone replacement therapy. JAMA 2001;285:171-6.
24. Laya MB, Gallagher JC, Schreiman JS, Larson EB, Watson P, Weinstein L. Effect of postmenopausal hormonal replacement therapy on mammographic density and parenchymal pattern. Radiology 1995;196:433-7.
25. del Carmen MG, Hughes KS, Halpern E, Rafferty E, Kopans D, Parisky YR, et al. Racial differences in mammographic breast density. Cancer 2003;98:590-6.
26. Lord SJ, Mack WJ, Van Den Berg D, Pike MC, Ingles SA, Haiman CA, et al. Polymorphisms in genes involved in estrogen and progesterone metabolism and mammographic density changes in women randomized to postmenopausal hormone therapy: Results from a pilot study. Breast Cancer Res 2005;7:R336-44.
27. Ursin G, Palla SL, Reboussin BA, Slone S, Wasilauskas C, Pike MC, et al. Post-treatment change in serum estrone predicts mammographic percent density changes in women who received combination estrogen and progestin in the Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. J Clin Oncol 2004;22:2842-8.
28. Banks E, Reeves G, Beral V, Bull D, Crossley B, Simmonds M, et al. Impact of use of hormone replacement therapy on false positive recall in the NHS breast screening programme: Results from the million women study. BMJ 2004;328:1291-2.